Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference

Read more ››
By: GlobeNewswire - 24 Apr 2024

Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update

Read more ››
By: GlobeNewswire - 24 Apr 2024

Good Supply Cannabis Introduces New Signature ‘Bud Squad’ Products

Read more ››
By: GlobeNewswire - 24 Apr 2024

Sharecare to report first quarter fiscal 2024 financial results on Thursday, May 9

Read more ››
By: GlobeNewswire - 24 Apr 2024

Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments

Read more ››
By: GlobeNewswire - 24 Apr 2024

LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units

Read more ››
By: GlobeNewswire - 24 Apr 2024

Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour

Read more ››
By: GlobeNewswire - 24 Apr 2024

First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients

Read more ››
By: GlobeNewswire - 24 Apr 2024

Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases

Read more ››
By: GlobeNewswire - 24 Apr 2024

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression

Read more ››
By: GlobeNewswire - 24 Apr 2024

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers

Read more ››
By: GlobeNewswire - 24 Apr 2024

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

Read more ››
By: GlobeNewswire - 24 Apr 2024

InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event

Read more ››
By: GlobeNewswire - 24 Apr 2024

Avenue Therapeutics Announces Reverse Stock Split

Read more ››
By: GlobeNewswire - 24 Apr 2024

Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B

Read more ››
By: GlobeNewswire - 24 Apr 2024

IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

Read more ››
By: GlobeNewswire - 24 Apr 2024
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate